Daily Archives: February 13, 2007

Ketek Gets New Label

The FDA announced the issuance of a new label for Ketek (telithromycin) that strips away two indications for use of the drug – acute bacterial sinusitis and acute bacterial exacerbations of chronic bronchitis – and retaining the sole remaining indication, … Continue reading

Posted in Risk Management | Comments Off on Ketek Gets New Label